Lanreotide Acetate API Manufacturers | Suppliers | Exporters

Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Switzerland

About the Company : Bachem, with over 50 years of experience, supplies products for research, clinical development, and commercial use to pharmaceutical and biotechnology companies worldwide. It has e...

Bachem, with over 50 years of experience, supplies products for research, clinical development, and commercial use to pharmaceutical and biotechnology companies worldwide. It has established itself as a leading, innovation-driven specialist in developing and manufacturing peptides and oligonucleotides. Headquartered in Switzerland with offices in Europe, the US, and Asia, Bachem is publicly listed on the SIX Swiss Exchange. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

02

Aspen API

Netherlands

Aspen API. More than just an API™

Netherlands

Lanreotide

About the Company : Aspen API is a cooperative entity formed by Aspen Oss in the Netherlands and Fine Chemicals Corporation in South Africa. The company supplies a broad portfolio of over 58 high-qual...

Aspen API is a cooperative entity formed by Aspen Oss in the Netherlands and Fine Chemicals Corporation in South Africa. The company supplies a broad portfolio of over 58 high-quality APIs, including high-potency products, oncology, peptides, narcotics, analgesics, botanical extractions, and biochemicals. Aspen API emphasizes quality, compliance, and teamwork, while integrating sustainable practices through the use of eco-friendly technologies and solvents in its manufacturing processes. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

03

ChemWerth Inc

U.S.A

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

U.S.A

About the Company : ChemWerth, established in 1982, is a US-headquartered full-service generic API company. It supplies cGMP-quality APIs to regulated markets worldwide, with exclusive partnerships fo...

ChemWerth, established in 1982, is a US-headquartered full-service generic API company. It supplies cGMP-quality APIs to regulated markets worldwide, with exclusive partnerships for product development, compliance, and secure logistics. ChemWerth accesses over 500 APIs and 30 manufacturing facilities across the US, Europe, India, and China, acts as a regulatory agent for 25+ FDA-approved facilities, sells 100+ products, and operates in 38 countries. In 2020, it filed its 500th DMF with the FDA . Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

04

Biophore India Pharmaceuticals Pvt ...

India

DCAT Week

Attending

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

India

About the Company : Biophore, founded in 2007, develops and manufactures niche and complex pharmaceutical products. With USFDA- and EU-approved API facilities, a dedicated intermediates site and an R&...

Biophore, founded in 2007, develops and manufactures niche and complex pharmaceutical products. With USFDA- and EU-approved API facilities, a dedicated intermediates site and an R&D center of 400 scientists, the company is a leading global API player. Biophore ranks among the top US DMF filers, holds 150+ patents and maintains a strong compliance record with major regulatory agencies. Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer

Product Web Link

05

LGM Pharma

U.S.A

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

U.S.A

About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for pharmaceutical and biotech industries. LGM also operates as a full-service CDMO, offering formulat...

LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for pharmaceutical and biotech industries. LGM also operates as a full-service CDMO, offering formulation, analytical method development and testing, custom API synthesis, regulatory support, and commercial manufacturing. Supported by a network of over 300 accredited cGMP manufacturing partners and more than 100,000 sq. ft. of FDA-inspected cGMP manufacturing and warehouse space, LGM delivers secure, end-to-end solutions across multiple dosage forms. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

06

Inabata France S.A.S

France

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

France

About the Company : Inabata France, established in 1990 and part of the Inabata Group, acquired Pharmasynthèse in 2006. Today, Inabata-Pharmasynthèse offers sourcing, manufacturing, and development ...

Inabata France, established in 1990 and part of the Inabata Group, acquired Pharmasynthèse in 2006. Today, Inabata-Pharmasynthèse offers sourcing, manufacturing, and development of raw materials for pharmaceutical and cosmetic industries, supplying Europe, Japan, and beyond. With expertise in fine chemicals, it manufactures from pilot to commercial scale at its GMP-certified facility in St. Pierre-Les-Elbeuf, France. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

07

Chunghwa Chemical Synthesis & Biote...

Taiwan

DCAT Week

Attending

Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.

Taiwan

About the Company : Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB) offers cost-effective APIs with speed, supported by a skilled team. As the first Southeast Asian company to receive FDA approv...

Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB) offers cost-effective APIs with speed, supported by a skilled team. As the first Southeast Asian company to receive FDA approval for synthetic and biotech APIs, CCSB has commercialized Statin, Immunosuppressant, Muscle Relaxant, and ACE Inhibitor APIs with complete DMF or COS. It partners with leading drug companies to develop and produce specialty APIs using advanced fermentation and synthesis technologies in Taiwan. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

08

Omgene Life Sciences Pvt. Ltd

India

Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

India

Digital Content